We also have X and podcasts
Wearable Anxiety Detection: Promising Sensors Need Clinical Proof
Wearable heart rhythm sensors show potential for objective anxiety monitoring, but most studies lack the rigor needed for clinical adoption.
Background
Anxiety disorders affect millions globally, yet clinical assessment relies largely on subjective self-reporting. Wearable ECG and PPG sensors offer potential for continuous, objective monitoring of anxiety-related physiological changes. A systematic review examined 38 studies to assess clinical readiness.
Key Findings
- RMSSD and high-frequency heart rate variability were the most consistent anxiety markers across studies
- 55% of studies used only healthy participants; only 13% included patients with diagnosed anxiety disorders
- Small studies (N<50) reported unrealistically high accuracies (96-99%); larger studies showed moderate, credible results
- No studies validated findings on independent datasets or demonstrated improved patient outcomes
- Signal collection duration (5 minutes to 2+ hours) varied widely, limiting cross-study comparison
Why It Matters
The review exposes a critical gap between promising laboratory findings and clinical readiness. While sensors detect anxiety-related physiology, current evidence lacks standardization, external validation, and proof that monitoring improves patient outcomes—essential for regulatory approval and real-world implementation.
Limitations
Most studies enrolled healthy volunteers rather than anxiety patients, limiting generalizability. Only 26% reported quantitative metrics, complicating cross-study comparison. Critically, none demonstrated that monitoring these signals actually improved patient care.
Original paper: Wearable ECG and PPG for anxiety detection: a translational digital medicine perspective. — NPJ digital medicine. 10.1038/s41746-026-02620-7
